Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C. (Q42980606)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Emanuela Orsi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Mariagrazia Rumi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Roberta D'Ambrosio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Elisabetta Degasperi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Gian Maria Prati

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Roberta Soffredini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Stella De Nicola

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Valeria Grancini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Massimo Colombo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

14 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1681-1687

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619107%20AND%20SRC:MED&resulttype=core&format=json

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

2 February 2020

cites work

1 reference

Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach

21 January 2018

1 reference

Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment

21 January 2018

1 reference

Hepatitis C virus infection: molecular pathways to metabolic syndrome

21 January 2018

1 reference

Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

The interaction of metabolic factors with HCV infection: does it matter?

21 January 2018

1 reference

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

21 January 2018

1 reference

Steatosis and insulin resistance in hepatitis C: a way out for the virus?

21 January 2018

1 reference

Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.

21 January 2018

1 reference

Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.

21 January 2018

1 reference

Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3

21 January 2018

1 reference

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

21 January 2018

1 reference

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.

21 January 2018

1 reference

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.

21 January 2018

1 reference

Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.

21 January 2018

1 reference

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients

21 January 2018

1 reference

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

Structural determinants that target the hepatitis C virus core protein to lipid droplets.

21 January 2018

1 reference

Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction

21 January 2018

1 reference

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

21 January 2018

1 reference

HCV infection and metabolic syndrome: which is the chicken and which is the egg?

21 January 2018

1 reference

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

Insulin resistance and insulin secretion in chronic hepatitis C virus infection

21 January 2018

1 reference

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

21 January 2018

1 reference

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

21 January 2018

1 reference

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

Clinical drivers in naïve patient eligibility for treatment of chronic hepatitis C.

21 January 2018

1 reference

Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action

21 January 2018

1 reference

Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.

21 January 2018

1 reference

Meta-analysis: insulin resistance and sustained virological response in hepatitis C.

21 January 2018

1 reference

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

21 January 2018

1 reference

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

Use of HOMA-IR in hepatitis C.

21 January 2018

1 reference

Telaprevir for retreatment of HCV infection

21 January 2018

1 reference

Boceprevir for previously treated chronic HCV genotype 1 infection

21 January 2018

1 reference